PH03L
Anti-PTP, T Cell (Ab-1) Mouse mAb (CF4-1D)
lyophilized, clone CF4-1D, Calbiochem®
Synonym(s):
Anti-Protein Tyrosine Phosphatase, T cell
Product Name
Anti-PTP, T Cell (Ab-1) Mouse mAb (CF4-1D), lyophilized, clone CF4-1D, Calbiochem®
biological source
mouse
antibody form
purified antibody
antibody product type
primary antibodies
clone
CF4-1D, monoclonal
form
lyophilized
does not contain
preservative
species reactivity
human
should not react with
mouse
manufacturer/tradename
Calbiochem®
storage condition
do not freeze
isotype
IgG2a
shipped in
ambient
storage temp.
2-8°C
Quality Level
Analysis Note
Positive Control
CCRF-CEM cells
CCRF-CEM cells
Application
Immunocytochemistry (see comments)
Immunoblotting (1-5 µg/ml)
Immunoprecipitation (1-2 µg/sample)
Immunoblotting (1-5 µg/ml)
Immunoprecipitation (1-2 µg/sample)
Disclaimer
Toxicity: Standard Handling (A)
General description
Purified mouse monoclonal antibody generated by immunizing mice with the specified immunogen and fusing splenocytes with SP2/0 mouse myeloma cells. Recognizes the PTPase protein.
Recognizes the T-cell PTPase protein.
This Anti-PTP, T Cell (Ab-1) Mouse mAb (CF4-1D) is validated for use in Immunocytochemistry, Immunoblotting, Immunoprecipitation for the detection of PTP, T Cell (Ab-1).
Immunogen
Human
recombinant, human T cell PTPase
Other Notes
Brown-Shimer, S., et al. 1992. Can. Res.52, 478.
Fischer, E.H., et al. 1991 Science253, 401.
Brown-Shimer, S., et al. Proc. Natl. Acad. Sci. USA87, 5148.
Chernoff, J., et al. 1990. Proc. Natl. Acad. Sci. USA87, 2735.
Cool, D.E., et al. 1990. Proc. Natl. Acad. Sci. USA87, 7280.
Charbonneau, H., et al. 1989. Proc. Natl. Acad. Sci. USA86, 5252.
Cool, D.E., et al. 1989. Proc. Natl. Acad. Sci. USA86, 5257.
Charbonneau, H., et al. 1988. Proc. Natl. Acad. Sci. USA85, 7182.
Fischer, E.H., et al. 1991 Science253, 401.
Brown-Shimer, S., et al. Proc. Natl. Acad. Sci. USA87, 5148.
Chernoff, J., et al. 1990. Proc. Natl. Acad. Sci. USA87, 2735.
Cool, D.E., et al. 1990. Proc. Natl. Acad. Sci. USA87, 7280.
Charbonneau, H., et al. 1989. Proc. Natl. Acad. Sci. USA86, 5252.
Cool, D.E., et al. 1989. Proc. Natl. Acad. Sci. USA86, 5257.
Charbonneau, H., et al. 1988. Proc. Natl. Acad. Sci. USA85, 7182.
This antibody has been reported to work for immunocytochemistry. Antibody should be titrated for optimal results in individual systems.
Physical form
Lyophilized from 20 mM sodium bicarbonate, 100 µg BSA.
Preparation Note
Reconstitute the lyophilized antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4 to yield a final concentration of 100 µg/ml. Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, aliquot and freeze (-20°C) for long-term storage or refrigerate (4°C) with 0.1% azide for short-term storage. Avoid freeze/thaw cycles of solutions.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Not finding the right product?
Try our Product Selector Tool.
Storage Class
10-13 - German Storage Class 10 to 13
Regulatory Information
新产品
This item has
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Marianne R Spalinger et al.
The Journal of clinical investigation, 126(5), 1783-1800 (2016-04-05)
Inflammasomes form as the result of the intracellular presence of danger-associated molecular patterns and mediate the release of active IL-1β, which influences a variety of inflammatory responses. Excessive inflammasome activation results in severe inflammatory conditions, but physiological IL-1β secretion is
Michael M Swarbrick et al.
Endocrinology, 150(4), 1670-1679 (2009-01-24)
Protein tyrosine phosphatase (PTP)-1B antagonizes insulin signaling and is a potential therapeutic target for insulin resistance associated with obesity and type 2 diabetes. To date, studies of PTP-1B have been limited by the availability of specific antagonists; however, treatment of
Claudia Penafuerte et al.
Oncoimmunology, 6(6), e1321185-e1321185 (2017-07-07)
PTP1B and TC-PTP are highly related protein-tyrosine phosphatases (PTPs) that regulate the JAK/STAT signaling cascade essential for cytokine-receptor activation in immune cells. Here, we describe a novel immunotherapy approach whereby monocyte-derived dendritic cell (moDC) function is enhanced by modulating the
Hui Guo et al.
Acta pharmacologica Sinica, 39(3), 425-437 (2017-11-10)
STAT1 and STAT3 are two important members of the STAT (signal transducers and activators of transcription) protein family and play opposing roles in regulating cancer cell growth. Suppressing STAT3 and/or enhancing STAT1 signaling are considered to be attractive anticancer strategies.
Ronald R Marchelletta et al.
The Journal of clinical investigation, 131(17) (2021-10-09)
Genome-wide association studies revealed that loss-of-function mutations in protein tyrosine phosphatase non-receptor type 2 (PTPN2) increase the risk of developing chronic immune diseases, such as inflammatory bowel disease (IBD) and celiac disease. These conditions are associated with increased intestinal permeability
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service